SYMDEKO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 01 Nov 2023)
What this means for you
Registered since 01 May 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87504249
- Registration number
- 5460641
- Mark type
- Design + words
- Filed
- 25 Jun 2017
- Published for opposition
- 31 Oct 2017
- Registered
- 01 May 2018
- Attorney of record
- Kelli A. Ovies
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cystic fibrosis
Owner
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
Prosecution history
- 01 Nov 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 01 Nov 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Nov 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 May 2023 — TEAS SECTION 8 & 15 RECEIVED
- 01 May 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 01 May 2018 — REGISTERED-PRINCIPAL REGISTER
- 27 Mar 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Mar 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Mar 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Feb 2018 — USE AMENDMENT FILED
- 06 Mar 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Feb 2018 — TEAS STATEMENT OF USE RECEIVED
- 26 Dec 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Nov 2017 — POST PUBLICATION AMENDMENT - ENTERED
- 31 Oct 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED